XMRV Helps MLV-Based Vectors Spread
Author Information
Author(s): Dong Beihua, Silverman Robert H., Kandel Eugene S.
Primary Institution: Cleveland Clinic, Cleveland, Ohio, United States of America
Hypothesis
Can XMRV complement replication-deficient MLV vectors in human cells?
Conclusion
XMRV can facilitate the spread of MLV-based vectors in human cells, raising safety concerns for gene therapy applications.
Supporting Evidence
- XMRV was found in 40% of prostate cancer patients with a specific genetic variant.
- XMRV can produce infectious vector particles in co-infected cells.
- MLV-based vectors are commonly used in gene therapy applications.
Takeaway
Scientists found that a virus called XMRV can help another virus, MLV, spread in human cells, which could be a problem for gene therapy.
Methodology
The study involved co-infection of cultured human cells with XMRV and MLV vectors to test for functional complementation.
Limitations
The study primarily focused on in vitro conditions, which may not fully represent in vivo scenarios.
Participant Demographics
20 prostate cancer patients, with varying RNase L activity.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website